explore -WSS

explore

author：explore 2025-09-03 07:35:42 - browse：6

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Medicare to pay more for cardiac rehab in hospital outpatient clinics

hotspot

WSS

The unintended consequences of overturning Roe v. Wade

Midwives could help bridge maternal health disparities in the U.S.

Readout LOUD podcast: Merger Mondays, Ozempic panic

House panel takes first step toward fixing drug shortages

Why the quest to eradicate polio has stumbled

Information blocking fines are now fair game in health care

focus

explore

focus

Bright Health sells Medicare Advantage business to Molina

Patients, doctors press FTC to beef up hospital merger scrutiny

Virginia high school admissions case could be legal follow

White House Covid adviser calls on docs to combat misinformation

Dobbs anniversary: the lost opportunity of abortion as health care

Takeaways from AdvaMed, the largest medical devices conference

Dobbs anniversary: the lost opportunity of abortion as health care

Humana CEO Bruce Broussard to step down in 2024

As demand for Covid shots wanes, Moderna seeks its next success

Takeaways from AdvaMed, the largest medical devices conference

entertainment

How should state employee insurance handle Wegovy?

Free Covid tests will again be offered to all U.S. households

FDA weighs limits of animal data in assessing artificial wombs

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Grad students accuse University of California of wage theft

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Wikipedia

hotspot

hotspot

explore